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Force-Sensing Catheters During Pediatric Radiofrequency Ablation:
The FEDERATION Study
Aarti S. Dalal, DO; Hoang H. Nguyen, MD; Tammy Bowman, MSN, ACNP; George F. Van Hare, MD; Jennifer N. Avari Silva, MD
Background-—Based on data from studies of atrial ﬁbrillation ablations, optimal parameters for the TactiCath (TC; St. Jude Medical,
Inc) force-sensing ablation catheter are a contact force of 20 g and a force-time integral of 400 gs for the creation of transmural
lesions. We aimed to evaluate TC in pediatric and congenital heart disease patients undergoing ablation.
Methods and Results-—Comprehensive chart and case reviews were performed from June 2015 to March 2016. Of the 102
patients undergoing electrophysiology study plus ablation, 58 (57%) underwent ablation initially with a force-sensing catheter.
Patients had an average age of 14 (2.4–23) years and weight of 58 (18–195) kg with 15 patients having abnormal cardiac anatomy.
Electrophysiology diagnoses for the +TC group included 30 accessory pathway–mediated tachycardia, 24 atrioventricular nodal
reentrant tachycardia, and 7 other. Baseline generator settings included a power of 20 W, temperature of 40°, and 6 cc/min ﬂow
during lesion creation with 11 patients (19%) having alterations to parameters. Seventeen patients (30%) converted to an alternate
ablation source. A total of 516 lesions were performed using the TC with a median contact force of 6 g, force-time integral of
149 gs, and lesion size index of 3.3. Median-term follow-up demonstrated 5 (10%) recurrences with no acute or median-term
complications.
Conclusions-—TactiCath can be effectively employed in the treatment of pediatric patients with congenital heart disease with lower
forces than previously described in the atrial ﬁbrillation literature. Patients with atrioventricular nodal reentrant tachycardia or
atrioventricular reciprocating tachycardia may not require transmural lesions and the TC may provide surrogate markers for
success during slow pathway ablation. ( J Am Heart Assoc. 2017;6:e005772. DOI: 10.1161/JAHA.117.005772.)
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T he estimated incidence of pediatric tachyarrhythmiasranges from 1:25 000 to as high as 1:2501 with
expanding use of transcatheter ablation for treating these
patients. Technological advances in interventional electro-
physiology (EP) are focused on enhancing patient outcomes
by improving acute success rates and decreasing recurrence
rates. One such advance in catheter technology has led to the
real-time quantiﬁcation of force applied by the ablation
catheter at the tip-tissue interface.2–7 Measurements of
contact force (CF) have been studied extensively in the adult
population, particularly in the ablation of atrial ﬁbrillation.
Several studies (Table S1) conducted in adult patients
primarily with an EP diagnosis of atrial ﬁbrillation (AF) have
concluded that optimal parameters for pulmonary vein
isolation include the combination of a CF of 20 gs,2,4,6,7 a
force-time integral (FTI) >400 g, and a lesion size index (LSI)
>5. The goal during pulmonary vein isolation, however, is
transmural lesions with no gaps in the isolation line. In
contrast to adult patients, the EP substrate for the majority of
pediatric patients undergoing ablation is reentrant supraven-
tricular tachycardia.
The goal of this study was to report on the ﬁndings of using
force-sensing catheters in a pediatric EP laboratory where the
majority of target EP substrates involve discrete circuits, such
as atrioventricular nodal reentrant tachycardia (AVNRT) and
accessory pathway (AP)–mediated tachycardia (atrioventricular
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reciprocating tachycardia [AVRT]) speciﬁcally with a focus on
the CF, FTI, and LSI used in these substrates compared with the
published data in the adult population with AF.
Methods
Upon approval from the institutional review board at Washing-
ton University School of Medicine and wavier of informed
consent, a detailed chart review was performed. Patient
demographic data, details of EP study (EPS)/ablation including
lesion data, complications, and outcome data were collected
from all patients undergoing EPS from June 2015 to March
2016. Regarding lesion data, average CF was collected for all
lesions, including FTI and LSI. Lesions were classiﬁed as
successful, unsuccessful, or consolidation. During an AP
ablation, a successful lesion was deﬁned as a lesion that
permanently (not transiently) interrupted AP conduction. Data
on the use of sheaths, including the use of standard (short, 7 or
7.5 F 12-cm sheath; St. Jude Medical, Inc) versus long
positioning (St. Jude Medical, Inc) sheaths, were collected.
As background, the institution acquired the St. Jude
Medical, Inc, force-sensing system hardware components
(TactiCath [TC], TactiSys, Ampere, and Cool Point pump; St.
Jude Medical, Inc) in June 2015. Practicing interventional
electrophysiologists elected to use the TC as the primary
ablation catheter for the laboratory beginning June 2015,
although physicians could opt out based on patient or
substrate characteristics. There were no set parameters for
CF, FTI, or LSI and physicians were not blinded to the CF data.
The FTI and LSI are calculated numbers to estimate lesion size
and depth2,3,6 and are both time-dependent variables.
Baseline settings for the system for this study included a
power of 20 W, a temperature of 40°C, and an irrigation ﬂow
rate during lesion formation of 6 cc/min. Additionally, preﬂow
and postﬂow times on the pump were adjusted to 1 second
for each parameter. Parameters were adjusted per physician
discretion from these baseline parameters.
Statistical Analysis
Results are presented as median values (with interquartile
range) and percentages. Statistical analyses were performed
using 2-tailed t tests of unequal variance as well as Fisher’s
exact and chi-square tests as appropriate. Statistical signif-
icance was set at P<0.05. All statistical calculations were
performed using Excel 2016 (Microsoft Corporation) and
SPSS (version 23.0; IBM Corp).
Results
Patient Data
A total of 121 patients presented for EPS during the study
timeframe, with 16% (19) excluded for undergoing isolated
EPS. The remaining 84% (102) of patients underwent EPS plus
transcatheter ablation. The TC was used in 57% (58) of
patients and as the sole ablation source in 39% (40) of
patients (Figure 1). Alternate energy sources were employed
in 17% (18) of patients with crossover to cryoablation in the
majority of cases. Physician choice to use an alternate
ablation catheter to the TC was most often because of a
retrograde approach to a left-sided substrate (16 of 44, 36%)
or the need for cryoablation (13 of 44, 30%) (Figure 2).
Physicians elected to not use the TC during retrograde
ablations as the catheter body is stiff and the team had
concerns regarding potential disruption of the aortic valve.
Patients who underwent ablation with the TC were older
and slightly larger than patients who underwent ablation with
alternate primary energy source or catheter (Table). EP
diagnoses were evenly distributed between the 2 groups,
although the +TC group did have more patients with
congenital heart disease (19% in the +TC group versus 9%
in the TC group) (Table and Table S2).
Lesion Data
A total of 516 lesions were performed in 58 patients using the
TC with a median CF of 6 g [interquartile range, 6], FTI of
153 gs [interquartile range, 310], and LSI of 3.4 [interquartile
Clinical Perspective
What is New?
• This is the ﬁrst study to assess the use of force-sensing
catheters (speciﬁcally TactiCath, St. Jude Medical, Inc) in a
pediatric electrophysiology laboratory where the majority of
target electrophysiology substrates involved discrete cir-
cuits, such as atrioventricular nodal reentrant tachycardia
and accessory pathway–mediated tachycardia (atrioventric-
ular reciprocating tachycardia).
• Lower forces are required compared with the published data
in the adult population with atrial ﬁbrillation.
• Operators applied higher contact forces when ablating
accessory pathway–mediated supraventricular tachycardias
compared with atrioventricular nodal reentrant tachycardia.
• During atrioventricular nodal reentrant tachycardia slow
pathway modiﬁcation, statistically signiﬁcant higher contact
force was seen during lesions where junctional rhythm was
observed.
What are the Clinical Implications?
• Force-sensing catheters can be effectively employed in the
treatment of pediatric and congenital ablation patients.
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range, 1.7] (Figure 3). Parameter settings were altered in 11
patients—9 patients had increased irrigation ﬂow (12–17 cc/
min) through the catheter during lesion formation, 3 patients
had uptitration of power (25–30 W), 1 patient had increased
temperature (42°), and 2 patients had alterations in multiple
parameters.
Figure 1. Flow chart demonstrating patient enrollment and patient movement through the study. CF
indicates contact force; EPS, electrophysiology study; RF, radiofrequency; TC, TactiCath.
Figure 2. Alternate energy source/ablation catheter. This ﬁgure illustrates the patients who were started
with the TactiCath (TC) and then converted to an alternate energy source or ablation catheter, as well as the
reason for changing the energy source. AP indicates accessory pathway; AVNRT, atrioventricular nodal
reentrant tachycardia; CF, contact force; CS, coronary sinus; LIS, left intermediate septal; RAL, right
anterolateral; RF, radiofrequency; RIJ, right internal jugular; RMS, right midseptal.
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Overall, ablation lesions placed during AP ablation had
higher CF when compared with slow pathway modiﬁcation
lesions placed for AVNRT (86.5 versus 53.7, P<0.01),
higher FTI (284306 versus 153176, P<0.01), and higher
LSI (3.71.2 versus 2.90.8, P=0.01) (Figure 3).
AP-Mediated Tachycardia
During AP ablations, higher forces were applied to left-sided
pathways compared with right-sided pathways (9.26.4
versus 7.76.6, P=0.08), thus leading to higher FTI
(365337 versus 223275, P<0.01) and LSI (41.3 versus
3.51.1, P<0.01) for left-sided lesions (Figure 4, Table S3).
Successful lesions, compared with unsuccessful lesions, had
higher CF (116.6 versus 7.96.6, P=0.02), FTI (614330
versus 199255, P<0.01), and LSI (4.81.2 versus 3.31,
P<0.01).
Atrioventricular Nodal Reentrant Tachycardia
When modifying slow pathway during AVNRT ablation cases
using a combined anatomic and electrogram-based approach,
ablation lesions that had an accelerated junctional rhythm
during the lesion had higher CF compared with lesions that
did not have junctional rhythm (64.2 versus 4.42, P<0.01)
and higher FTI (189202 versus 8989, P<0.01) and LSI
(3.10.8 versus 2.80.6, P=0.01) (Figure S1).
Table. Patient Demographic and Substrate Data
Total No. +TC TC P Value
Total patients, No. 102 58 44
Sex, % (No.)
Female 41 (42) 60 (25) 40 (17) 0.68
Male 59 (60) 55 (33) 45 (27)
Age, y 144 153.2 12.65 0.01
Weight, kg 6030 64.831 5427 0.07
Height, cm 15921 16416 15425 0.07
EP diagnosis 108
AP-mediated, % (No.) 54 (59) 51 (30) 49 (29)
Right-sided accessory
pathways, % (No.)
40 (12) 41 (12)
Left-sided accessory
pathways, % (No.)
60 (18) 59 (17)
AVNRT, % (No.) 36 (39) 62 (24) 38 (15)
Typical, % (No.) 88 (21) 100 (15)
Atypical, % (No.) 12 (3) 0
PVCs/VT, % (No.) 5 (5) 20 (1) 80 (4)
AFL, % (No.) 3 (3) 100 (3) 0
AT, % (No.) 2 (2) 100 (2) 0
Structurally abnormal
hearts, % (No.)
15 (15) 19 (11) 9 (4)
CHD 9 (5) 5 (2)
Ebstein’s anomaly 2 0
Aortic valve disease 1 2




CM (hypertrophic) 2 (2) 2 (1) 2 (1)
CS abnormalities/
diverticulum
4 (4) 5 (3) 2 (1)
OHT 1 (1) 2 (1) 0
No. of lesions 108 119 85 0.02
Acute success,
% (No.)
89 (91) 88 (51) 91 (40)
Recurrence,
% (No.)
7 (7) 8 (5) 5 (2)
AFL indicates atrial ﬂutter; AP, accessory pathway; AT, atrial tachycardia; AVNRT,
atrioventricular nodal reentrant tachycardia; CHD, congenital heart disease; CM,
cardiomyopathy; CS, coronary sinus; OHT, orthotopic heart transplant; PVCs, premature
ventricular contractions; TC, TactiCath; VT, ventricular tachycardia.
Figure 3. Box whisker plots for all lesions placed with the
TactiCath. A, Demonstrates that lesions placed during accessory
pathway (AP) ablations had signiﬁcantly higher contact force (CF)
than lesions placed for atrioventricular nodal reentrant tachycar-
dia (AVNRT) (P<0.01). B and C, Iterate that ﬁnding for force-time
integral (FTI) and lesion size index (LSI) (P<0.01 for each).
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There were 6 patients who underwent TC ablation with other
tachycardia substrates including atrial tachycardia (n=2; 3 foci
with 2 left atrial and 1 right atrial), atrial ﬂutter (n=3; 3 right
atrial ﬂutter circuits, 1 left atrial ﬂutter), and left ventricular
(Belhassen) ventricular tachycardia (n=1) (Table S3).
Standard (Short) Sheath versus Long Positioning
Sheaths
Of the total 516 CF lesions placed, 396 (77%) were placed
using a long positioning sheath, most commonly SR0 and
Mullins transseptal sheaths (St. Jude Medical, Inc). Figure 5
demonstrates that for those lesions placed on the right-sided
atrioventricular valve annulus (AVVA), lesions applied with
standard (short) sheaths achieved higher CF (9.98.2 versus
5.74, P<0.05), FTI (324345 versus 155170, P<0.05),
and LSI (3.71.3 versus 3.20.8, P<0.05) compared with
lesions applied with long (positioning) sheaths. Conversely, for
lesions applied to the left-sided AVVA, lesions applied with
long (positioning) sheaths (following a transseptal puncture)
achieved higher CF (129.9 versus 6.53.6, P<0.05), FTI
(506555 versus 263133, P<0.05), and LSI (4.41.3
versus 3.60.8, P<0.05) compared with left-sided lesions
placed with a short (standard) sheath via patent foramen
ovale.
Nine patients started with a short sheath, which was then
upsized to a positioning sheath (right-sided AP, n=5; AVNRT,
n=2; left-sided AP, n=1; and left-sided AFL, n=1). In this
cohort of patients, when comparing lesions placed with short
versus long sheaths, there was no statistically signiﬁcant
difference in CF (77 versus 8.36.5, P=0.4), FTI (179223
versus 262306, P=0.06), or LSI (3.31 versus 3.71,
P=0.08).
Patient Follow-Up and Complications
There were no complications noted during the study period.
There were a higher number of recurrences noted in the +TC
group (10% in +TC group versus 5% in TC group, P=0.4)
(Table). This difference likely reﬂects the operator learning
curve with the new technology, but it is noteworthy that all 3
left-sided lesions that recurred required more than one
approach to the AP and more than one energy source. One of
the +TC recurrences was in a patient with atypical AVNRT
requiring ablation within a coronary sinus diverticulum. The
ﬁnal recurrence in the +TC cohort was a complex ﬂutter case
in a patient with orthotopic heart transplant. This underscores
the difﬁcultly of these cases.
Discussion
To our knowledge, this is the ﬁrst study to evaluate the utility
and safety of force-sensing catheters during RF ablation in
pediatric and congenital patients. Furthermore, it is the ﬁrst
study to evaluate purely macroreentrant EP substrates, such
as AVRT and AVNRT. This study demonstrates that the TC can
be used safely for patients undergoing AVRT and AVNRT
ablations in both the right and left atrium and that successful
lesions require dramatically lower CF than that reported in the
adult AF literature (Table). Additionally, we found that
operators applied higher CFs when ablating AP-mediated
supraventricular tachycardias compared with AVNRTs. During
AVNRT slow pathway modiﬁcation, statistically signiﬁcant
higher CF was seen during lesions where junctional rhythm
was observed. Lastly, there was an increased recurrence rate
noted in the TC group.
These ﬁndings are different than the published literature on
AF. This difference is likely attributable to the different
Figure 4. Box whisker plots for lesion data made during
accessory pathway (AP) ablations. A, Illustrates that there was
no signiﬁcant difference in contact force (CF) applied to right-
sided (R-sided) or left-sided (L-sided) APs. B and C, Demonstrate
that the force-time integral (FTI) and lesion size index (LSI) were
signiﬁcantly higher for L-sided lesions. This ﬁnding may be
explained by longer duration of lesions on the L-sided atrioven-
tricular valve annulus.
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substrate and end goals in the reported populations. Trans-
mural lesion creation is a goal for patients undergoing AF
ablation. Pulmonary vein isolation remains the primary
therapeutic strategy for transcatheter ablation of this sub-
strate and a full thickness lesion is thought to be needed for
electrical isolation.
Conversely, both AVNRT and pathway-mediated AVRT have
more discrete ablation targets that theoretically should not
require transmurality. In the case of typical AVNRT, the
ablation target is slow pathway modiﬁcation in the region of
the lower to mid third of the triangle of Koch. Aggressive
transmural lesions low in the triangle could conceivably result
in inadvertent damage of the coronary artery system.8–11
Likewise, deep lesions higher in the triangle of Koch can result
in damage to the atrioventricular node.8,11 Similarly, the
majority of APs are thought to usually be endocardial
structures, as evidenced by transient mechanical interruption
of pathway conduction during catheter manipulation. As such,
ablation of these substrates typically should not require
transmural lesions. The ﬁndings in this study are consistent
with previous conclusions.
During slow pathway modiﬁcations for typical AVNRT
ablations, junctional rhythm was seen in those lesions with
higher CF. Indeed, during the use of non–force-sensing
Figure 5. Use of standard (short) vs long positioning sheaths comparing right-sided (R-sided) vs left-sided (L-sided) lesions, contact force (CF),
force-time integral (FTI), and lesion size index (LSI) data. A, Demonstrates that the majority of lesions on both the R- and L-sided atrioventricular
valve annulus (AVVA) were placed using long sheaths. In (B), CF (in grams) is compared by R- and L-sided AVVA as well as sheath. There was
signiﬁcantly more contact applied during R-sided short sheath lesions compared with R-sided long sheath lesions, with the converse noted on
the L-sided AVVA. For lesions placed exclusively by short sheaths, there were greater forces applied to the R-sided vs L-sided lesions and the
converse was seen with lesions applied with long sheaths, where L-sided lesions had greater forces than R-sided lesions. C, Illustrating that the
FTI (in gs) and (D) the LSI both demonstrate that higher FTI/LSI were achieved on R-sided lesions using short compared with long sheaths, with
the converse for L-sided lesions where long sheath lesions achieved greater FTIs.
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radiofrequency catheters for AVNRT ablation, the presence of
accelerated junctional rhythm has been used as a surrogate
marker of successful lesion formation.7 In this study, we
conﬁrmed that lesions with a higher CF did have more
junctional rhythm during lesion creation.
Interestingly, lesions placed with long (positioning) sheaths
did not necessarily result in increased CF. In fact, lesions
placed on the right AVVA with short (standard) sheaths had
higher CF than those placed with long sheaths. Long sheaths
are often employed for catheter stability. This is particularly
important when performing AVNRT slow pathway modiﬁca-
tions where balancing a septal location without sliding into
the coronary sinus is critical, or on regions on the right AVVA
where it can be difﬁcult to balance, such as the lateral wall.
This is in direct contrast to left-sided lesions, where lesions
placed though long sheaths did have higher CF than those
lesions placed via short (standard) sheaths. However, it is
important to note that long positioning sheaths are placed
into the left atrium following a transseptal puncture. For
patients with an atrial level shunt, no long sheaths were
placed into the left atrium. In general, traversing the atrial
septum through a patent foramen ovale to access the left
AVVA results in a catheter orientation that is challenging for
the operator to balance and achieve high CF. This may
account for less CF applied during those lesions placed with a
short sheath on the left AVVA.
There were no adverse events reported during the study
period either acutely (during the procedure) or during median-
term follow-up. This is particularly noteworthy since irrigated
tip radiofrequency ablation catheters are not routinely used in
pediatric patients with structurally normal hearts. Our strat-
egy of limiting ﬂow through the catheter both during and pre/
post lesion formation perhaps contributed to mitigating this
risk. There was an increase in the recurrence rate in patients
in the TC group, attributable to: (1) increased incidence of
structurally abnormal hearts, and (2) operator learning curve,
resulting in potentially less aggressive lesion sets.
Limitations
There are inherent study limitations attributable to the
learning curve associated with adopting new technology. This
was particularly important in this study since before using the
TC, most radiofrequency ablations at this institution used
standard, dry-tip radiofrequency ablation catheters rather
than irrigated tip catheters. Additionally, the decision to
convert to a different catheter or mode of ablation limited the
number of patients in the study. Patient enrollment was
further limited by the unidirectional curve on the CF ablation
catheter, as the operators chose bidirectional catheters when
approaching certain APs, or during premature ventricular
contractions/right ventricular outﬂow tract–ventricular
tachycardia ablations. Importantly, operators were not blinded
to force measurements during ablations. Therefore, changes
to ablation technique (guiding therapy based on force data),
although not intentional or deliberate, may have biased the
operators. The long-term success of CF in pediatric patients
cannot be properly extrapolated from this study, and therefore
lesion data cannot consistently be correlated to patient
outcome. Finally, the number of patients in this single
institution study was small, and additional data acquisition
is required to better understand the role of CF in pediatric
patients.
Conclusions
TactiCath can be effectively employed in the treatment of
pediatric and congenital patients with lower forces than
previously described in the adult AF literature. Patients with
AVNRT or AVRT may not require transmural lesions and the TC
may provide surrogate markers for success during slow
pathway ablation in AVNRT. Use of long sheaths did not
universally correspond with increased CF.
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Table S1. Published clinical trials evaluating TactiCath.   
 
 
Abbreviations: AF=atrial fibrillation, SVT=supraventricular tachycardia, CF=contact force, 
RA=right atrium, LA=left atrium, FTI=force time integral. 
 






Table S2. Other Electrophysiologic Substrates.   
 
Abbreviations: CF=contact force, FTI=force time integral, LSI=lesion size index, EAT=ectopic 
atrial tachycardia, AFL=atrial flutter, VT=ventricular tachycardia 






Table S3. Locations of Accessory Pathways for patients undergoing ablation with (left) and 
without (right) TactiCath.   
 
 
Abbreviation: AP=accessory pathway. 
 
  






Figure S1. Box Whisker Plots for lesion data during AVNRT slow pathway modification.  Panel 
A demonstrates that lesions during which junctional rhythm was noted had statistically 
significant higher contact force (CF) when compared to those lesions where there was no 
junctional rhythm observed.  Panels B and C also consistently demonstrate significantly higher 
force-time integral (FTI) and lesion size index (LSI) in those lesions where junctional rhythm 
was observed. 
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